CSL

csl-logo

CSL Limited is a public company which is a parent company of the CSL Group. CSL business activities operate in the Human Health, JRH Biosciences, Animal Health and ZLB Plasma Services operations. CSL limited develops, manufactures and markets pharmaceutical products of biological origin. The company' s business is: - Health care; - Life-saving products derived from human plasma; - Pharmaceuticals and diagnostics essential to health; - Cell culture reagents for the pharmaceutical industry; - Veterinary vaccines and diagnostics to protect livestock and companion animals.

#People #Financial #Event #Website #More

CSL

Social Links:

Industry:
Biotechnology Health Care Health Diagnostics Medical

Founded:
1916-01-01

Address:
Parkville, New South Wales, Australia

Country:
Australia

Website Url:
http://www.csl.com

Total Employee:
10001+

Status:
Active

Contact:
61393878454

Email Addresses:
[email protected]

Total Funding:
111 M USD

Technology used in webpage:
Apple Mobile Web Clips Icon Apache Mobile Non Scaleable Content Amazon JsDelivr Cloudflare JS CDN JS ASP.NET Apple Mobile Web App Capable JQuery CDN



Current Advisors List

john-akehurst_image

John Akehurst Board of Directors @ CSL
Board_member

marie-mcdonald_image

Marie McDonald Board of Directors @ CSL
Board_member

christine-oreilly_image

Christine Oโ€™Reilly Board of Directors @ CSL
Board_member

bruce-brook_image

Bruce Brook Board of Directors @ CSL
Board_member

david-anstice_image

David Anstice Member of the Board of Directors @ CSL
Board_member

maurice-renshaw_image

Maurice Renshaw Board of Directors @ CSL
Board_member

Current Employees Featured

ghazal-hariri_image

Ghazal Hariri
Ghazal Hariri Investigator @ CSL
Investigator
2019-01-01

john-shine_image

John Shine
John Shine Chairman @ CSL
Chairman

sandro-krug_image

Sandro Krug
Sandro Krug Human Resources Director Intercontinental Commercial Operations @ CSL
Human Resources Director Intercontinental Commercial Operations
2022-01-01

joy-linton_image

Joy Linton
Joy Linton Chief Financial Officer @ CSL
Chief Financial Officer
2021-03-01

paul-perreault_image

Paul Perreault
Paul Perreault Chief Executive Office and Managing Director @ CSL
Chief Executive Office and Managing Director

not_available_image

Peter Turner
Peter Turner President of CSL Behring @ CSL
President of CSL Behring

not_available_image

Brian A. McNamee
Brian A. McNamee CEO @ CSL
CEO

Stock Details


Company's stock symbol is ASX:CSL

Acquisitions List

Date Company Article Price
2021-12-14 Vifor Pharma Vifor Pharma acquired by CSL 11.7 B USD
2017-08-28 Calimmune Calimmune acquired by CSL 91 M USD
2017-06-12 Wuhan Zhong Yuan Rui De Biological Products Wuhan Zhong Yuan Rui De Biological Products acquired by CSL 352 M USD

Investments List

Date Company Article Money raised
2020-09-28 Ena Respiratory CSL investment in Series A - Ena Respiratory 11.7 M AUD
2019-09-26 Denteric CSL investment in Series A - Denteric 14 M AUD
2000-05-30 eBioinformatics CSL investment in Venture Round - eBioinformatics 10 M USD

Key Employee Changes

Date New article
2020-02-24 DMO appoints CSL as new stockbrokers to FGN

Official Site Inspections

http://www.csl.com Semrush global rank: 318.65 K Semrush visits lastest month: 194.8 K

  • Host name: csl.com
  • IP address: 12.3.33.229
  • Location: Atlanta United States
  • Latitude: 33.9707
  • Longitude: -84.3247
  • Metro Code: 524
  • Timezone: America/New_York
  • Postal: 30338

Loading ...

More informations about "CSL"

Global Biotechnology Company | CSL

CSL. Always Evolving for a Better World. CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and โ€ฆSee details»

Our Leadership - CSL

The Board is responsible for the oversight and strategic direction of CSL. It monitors operational and financial performance, human resources policies and practices, and approves the company's budgets and business plans. It is also โ€ฆSee details»

We Are CSL | CSL

CSL Vifor, a leader in iron deficiency and nephrology. Together, our combined and robust histories are delivering a healthier today and a better tomorrow for patients and people โ€ฆSee details»

Our Corporate Profile | Global Biotechnology Company โ€ฆ

Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL -including our three businesses, CSL Behring, CSL Seqirus and CSL Vifor - provides lifesaving products to patients โ€ฆSee details»

CSL LAUNCHES NEW UNIFIED GLOBAL BRAND IDENTITY

Aug 10, 2022 CSL (ASX: CSL; USOTC: CSLLY) is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, as well as vaccines to โ€ฆSee details»

CSL Seqirus | About Us

CSL Seqirus supports Canadaโ€™s public health focus on seasonal influenza vaccination and works to help ensure the success of those programs. As a long-standing partner to Canadaโ€™s pandemic planning, we hold the contract as the โ€ฆSee details»

Sustainability at CSL - CSL Behring

CSL is committed to a healthier world. Our vision is a sustainable future for our employees, communities, patients and donors, inspired by innovative science and a values-driven culture. ... and ethical behaviors with integrity and further โ€ฆSee details»

Our Businesses and Products - CSL

For over a century, weโ€™ve been an unstoppable force, from developing medicines that save and improve lives to vaccines that protect them. Today, with the combined expertise of CSL Behring (with oversight to CSL Plasma), CSL โ€ฆSee details»

News Releases | CSL

Oct 19, 2022 Today, CSL โ€“ including our three businesses, CSL Behring, CSL Seqirus and CSL Vifor โ€“ provides lifesaving products to patients in more than 100 countries and employs 30,000 โ€ฆSee details»

CSL - Crunchbase Company Profile & Funding

CSL Limited is a public company which is a parent company of the CSL Group. CSL business activities operate in the Human Health, JRH Biosciences, Animal Health and ZLB Plasma Services operations. CSL limited develops, โ€ฆSee details»

CSL - LinkedIn

CSL | 251,330 followers on LinkedIn. CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune โ€ฆSee details»

Thought Leadership - CSL

Nov 7, 2023 CSLโ€™s Debbie Drane recently spoke on a panel about how to keep momentum going following a record-setting year for cell and gene therapies. Apr 3, 2023. CSL's new CEO โ€ฆSee details»

Presentations | Global Biotechnology Company | CSL - CSL Limited

CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Together they help ensure people everywhere get the treatments they need.See details»

Global Biotechnology Company - CSL

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patientsโ€™ needs by using the latest technologies, we discover, develop and deliver โ€ฆSee details»

Corporate Governance - CSL

The Board believes that CSL complies with the ASX Corporate Governance Council's Revised Corporate Governance Principles and Recommendations. Furthermore, the Board and โ€ฆSee details»

Annual Reports | Global Biotechnology Company | CSL - CSL Limited

CSL's latest and archived Annual Reports. Set new initial goals in support of performance across CSLโ€™s sustainability focus areas that seek to enable a healthier world, also embedding health โ€ฆSee details»

Canadian Soccer League

Canadaโ€™s Professional League The Canadian Soccer League (CSL) is long-standing and is the highest level league in Canada. It is a continuation of earlier forerunner leagues, the National โ€ฆSee details»

Healthier Communities - CSL

CSL has evolved its sustainability strategy during FY2024, with the goal of deploying its resources to service stakeholders in the focus areas of Access and Affordability, Patient Experience and โ€ฆSee details»

Sustainability | CSL

CSL holds more than 5,000 active and valid product registrations (including varying vial sizes) in over 100 countries, supporting newborns through to the elderly. Our support for patient groups โ€ฆSee details»